Skip to Main Content

Paper Details

Safety and improved efficacy signals following gene therapy in childhood blindness caused by <i>GUCY2D</i> mutations.
iScience
22
2021
Author NameAffiliation
Samuel G JacobsonScheie Eye Institute, Perelman School of Medicine, University of Pennsylvania
Artur V CideciyanScheie Eye Institute, Perelman School of Medicine, University of Pennsylvania
Allen C HoWills Eye Hospital, Thomas Jefferson University
  • 1 - 3

Datasets

Release 1.2